ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.0500
-0.0100 (-16.67%)
At close: Jul 30, 2026
ProPhase Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4.08 | 4.35 | 6.77 | 34.98 | 122.65 | 79.04 | |
Revenue Growth | -30.14% | -35.82% | -80.65% | -71.48% | 55.17% | 444.59% |
Cost of Revenue | 2.93 | 2.96 | 6.92 | 19.43 | 51.99 | 37.05 |
Gross Profit | 1.15 | 1.38 | -0.15 | 15.56 | 70.65 | 41.99 |
Selling, General & Admin | 17.95 | 19.32 | 37.89 | 35.37 | 46.41 | 31.67 |
Research & Development | 0.01 | 0.11 | 0.59 | 1.4 | 0.65 | 0.52 |
Total Operating Expenses | 17.96 | 19.43 | 38.48 | 36.78 | 47.06 | 32.19 |
Operating Income | -16.81 | -18.05 | -38.63 | -21.22 | 23.6 | 9.8 |
Interest Income | - | -0.17 | - | 0.08 | 0.15 | 0.64 |
Interest Expense | -7.05 | -6.93 | -3.35 | -1.27 | -0.76 | -1.15 |
Other Non-Operating Income (Expense) | 0.32 | 1.76 | -0.35 | 0.01 | -0.08 | -3.99 |
Total Non-Operating Income (Expense) | -6.72 | -5.34 | -3.7 | -1.18 | -0.69 | -4.5 |
Pretax Income | -22.51 | -23.39 | -42.33 | -22.4 | 22.91 | 5.31 |
Provision for Income Taxes | 1.37 | - | 7.2 | -6.02 | 4.45 | -0.97 |
Net Income | -23.88 | -23.39 | -49.53 | -16.38 | 18.46 | 6.27 |
Net Income to Common | -23.88 | -14.74 | -53.36 | -16.78 | 18.46 | 6.27 |
Net Income Growth | - | - | - | - | 194.32% | - |
Shares Outstanding (Basic) | 11 | 8 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 11 | 8 | 2 | 2 | 2 | 2 |
Shares Change | 339.82% | 324.45% | 16.23% | -7.74% | 1.40% | 58.63% |
EPS (Basic) | -0.76 | -1.74 | -26.68 | -9.80 | 11.70 | 4.10 |
EPS (Diluted) | -0.76 | -1.74 | -26.68 | -9.80 | 10.20 | 4.00 |
EPS Growth | - | - | - | - | 155.00% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -5.71 | -8.34 | -18.44 | -13.97 | 24.63 | -17.85 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.53 | -0.98 | -9.22 | -8.12 | 13.21 | -9.70 |
Gross Margin | 28.24% | 31.85% | -2.22% | 44.47% | 57.61% | 53.12% |
Operating Margin | -411.71% | -415.35% | -570.59% | -60.66% | 19.24% | 12.40% |
Profit Margin | -584.96% | -538.25% | -731.54% | -46.82% | 15.05% | 7.94% |
FCF Margin | -139.87% | -192.04% | -272.44% | -39.94% | 20.08% | -22.58% |
EBITDA | -12.5 | -13.22 | -32.44 | -15.17 | 28.31 | 13.04 |
EBITDA Margin | -306.10% | -304.14% | -479.20% | -43.36% | 23.09% | 16.49% |
EBIT | -16.81 | -18.05 | -38.63 | -21.22 | 23.6 | 9.8 |
EBIT Margin | -411.71% | -415.35% | -570.59% | -60.66% | 19.24% | 12.40% |
Effective Tax Rate | -6.10% | 0.00% | -17.00% | 26.87% | 19.40% | -18.25% |